The first sentence of the second paragraph in the section headed BChanges in the bone turnover markers' concentrations in response to teriparatide treatment^should have read as follows: BIn the nonresponders, the mean (SD) uNTX levels increased to 73 nmol BCE/mmol Cr (59) at 4 months, 87 nmol BCE/mmol Cr (64) at 8 months, 84 nmol BCE/mmol Cr (53) at 12 months, 86 nmol BCE/mmol Cr (64) at 16 months, 80 nmol BCE/mmol Cr (74) at 20 months, and 77 nmol BCE/mmol Cr (99) at 24 months (all p < 0.01 vs. baseline; Wilcoxon signed-rank test) (Fig. 2b) ^. In addition, both panels Fig. 1 contained errors. The amended figure is given here. The authors apologise for any inconvenience caused.
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